Skip to main content
SpringerLink
Log in

Heavy Menstrual Bleeding

  • Chapter
  • First Online:
Management of Bleeding Patients

Abstract

Heavy menstrual bleeding (HMB), a common complaint in adolescent and adult women, can be due to a variety of causes ranging from anovulatory bleeding, bleeding disorders, endocrine abnormalities, infectious etiology, pregnancy/miscarriage, and anatomic abnormalities of the reproductive organs. Comprehensive evaluation of the patient by the gynecologist and hematologist working in conjunction will enable prompt detection of the underlying cause and timely institution of therapy. In general, HMB can be managed with hormonal therapy and general hemostatic therapy; in patients with bleeding disorders, specific hemostatic therapy directed toward the underlying disorder can be given as primary or supplemental therapy. Appropriate medical or interventional therapy for other etiologies and management of hematologic and gynecologic complications of HMB will help to improve the patient’s overall quality of life. Patient-centered efforts and use of innovative technology for HMB can enhance patient awareness and education and promote participation in their care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. James AH. Bleeding disorders in adolescents. Obstet Gynecol Clin North Am. 2009;36(1):153–62.

    Article  PubMed  Google Scholar 

  2. Venkateswaran L, Dietrich JE. Gynecologic concerns in pubertal females with blood disorders. J Pediatr Adolesc Gynecol. 2013;26(2):80–5.

    Article  PubMed  Google Scholar 

  3. James AH. Women and bleeding disorders. Haemophilia. 2010;16 Suppl 5:160–7.

    Article  PubMed  Google Scholar 

  4. Oehler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand. 2003;82:405–22.

    Article  CAS  PubMed  Google Scholar 

  5. Shaw JA, Shaw HA. Menorrhagia. http://www.emedicine.com/med/topic1449.htm/.

  6. Friberg B, Orno AK, Lindgren A, et al. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand. 2006;85:200–6.

    Article  PubMed  Google Scholar 

  7. Pawar A, Krishnan R, Davis K, Bosma K, Kulkarni R. Perceptions about quality of life in a school-based population of adolescents with menorrhagia: implications for adolescents with bleeding disorders. Haemophilia. 2008;14(3):579–83.

    Article  CAS  PubMed  Google Scholar 

  8. ACOG Committee on Practice Bulletins—Gynecology. American College of Obstetricians and Gynecologists. Diagnosis of Abnormal uterine bleeding in reproductive aged women. Obstet Gynecol. 2012;120(1):197–206. ACOG practice bulletin: #218.

    Article  Google Scholar 

  9. ACOG Committee on Adolescent Health Care. ACOG Committee Opinion No. 349, November 2006: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol. 2006;108(5):1323–8.

    Article  Google Scholar 

  10. ACOG Committee on Practice Bulletins--Gynecology. American College of Obstetricians and Gynecologists. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet. 2001;72:263–71.

    Article  Google Scholar 

  11. Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem. 1984;20:231–6.

    Article  CAS  PubMed  Google Scholar 

  12. Gray SH, Emans SJ. Abnormal vaginal bleeding in adolescents. Pediatr Rev. 2007;28:175–82.

    Article  PubMed  Google Scholar 

  13. Fraser IS, Critchley HOD, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29:383–90.

    Article  PubMed  Google Scholar 

  14. Byams VR, Kouides PA, Kulkarni R, Baker JR, Brown DL, Gill JC, Grant AM, James AH, Konkle BA, Maahs J, Dumas MM, McAlister S, Nance D, Nugent D, Philipp CS, Soucie JM, Stang E, Haemophilia Treatment Centres Network Investigators. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia. 2011;17 Suppl 1:6–13.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Diaz R, Dietrich J, Mahoney Jr D, et al. Prevalence of bleeding disorders in adolescents with heavy menstrual bleeding. J Pediatr Adolesc Gynecol. 2014;27:324–9.

    Article  PubMed  Google Scholar 

  16. Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.

    Article  PubMed  Google Scholar 

  17. Doufas AG, Mastorakos G. The hypothalamic-pituitary-thyroid axis and the female reproductive system. Ann N Y Acad Sci. 2000;900:65–76.

    Article  CAS  PubMed  Google Scholar 

  18. Michiels JJ, Budde U, van der Planken M, et al. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol. 2001;14(2):401–36.

    Article  CAS  PubMed  Google Scholar 

  19. American College of Obstetricians and Gynecologists Committee on Adolescent Health Care, American College of Obstetricians and Gynecologists Committee Gynecologic Practice. ACOG Committee Opinion No. 451: Von Willebrand disease in women. Obstet Gynecol. 2009;114(6):1439–43.

    Article  Google Scholar 

  20. Bowman M, Mundell G, Grabell J, et al. Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost. 2008;6(12):2062–6.

    Article  CAS  PubMed  Google Scholar 

  21. O'Brien SH. Bleeding scores: are they really useful? Hematology Am Soc Hematol Educ Program. 2012;2012:152–6.

    PubMed  Google Scholar 

  22. Philipp CS, Faiz A, Heit JA, Kouides PA, Lukes A, Stein SF, Byams V, Miller CH, Kulkarni R. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol. 2011;204(3):209.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–9.

    Article  CAS  PubMed  Google Scholar 

  24. Reid P, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG. 2000;107(3):320–2.

    Article  CAS  PubMed  Google Scholar 

  25. Sanchez J, Andrabi S, Bercaw JL, Dietrich JE. Quantifying the PBAC in a pediatric and adolescent gynecology population. BJOG. 2000;107(3):320–2.

    Article  Google Scholar 

  26. Sidonio RF, Smith KJ, Ragni MV. Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia. J Pediatr. 2010;157:456–60.

    Article  PubMed  Google Scholar 

  27. Khamees D, Klima J, O'Brien SH. Population screening for von Willebrand disease in adolescents with heavy menstrual bleeding. J Pediatr. 2015;166:195–7.

    Article  PubMed  Google Scholar 

  28. Mikhail S, Kouides P. von Willebrand disease in the pediatric and adolescent population. J Pediatr Adolesc Gynecol. 2010;23 Suppl 6:S3–10.

    Article  PubMed  Google Scholar 

  29. Philipp CS, Dilley A, Miller CH, et al. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost. 2003;1(3):477–84.

    Article  CAS  PubMed  Google Scholar 

  30. Philipp CS. Platelet disorders in adolescents. J Pediatr Adolesc Gynecol. 2010;23 Suppl 6:S11–4.

    Article  PubMed  Google Scholar 

  31. Sokkary NA, Venkateswaran L, Dietrich JE, Teruya J. Platelet function disorders and menorrhagia in adolescents: a review of laboratory diagnosis. J Pediatr Adolesc Gynecol. 2012;25(4):233–7.

    Article  PubMed  Google Scholar 

  32. Venkateswaran L, Yee DL. Rare bleeding disorders in young women. J Pediatr Adolesc Gynecol. 2010;23(6 Suppl):S38–42.

    Article  PubMed  Google Scholar 

  33. Mehta R, Shapiro AD. Plasminogen activator inhibitor type 1 deficiency. Haemophilia. 2008;14(6):1255–60.

    Article  CAS  PubMed  Google Scholar 

  34. Whiting D, Dinardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89(2):228–32.

    Article  CAS  PubMed  Google Scholar 

  35. Naik S, Teruya J, Dietrich JE, et al. Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia. Pediatr Blood Cancer. 2013;60(7):1184–7.

    Article  PubMed  Google Scholar 

  36. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (vWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171.

    Article  CAS  PubMed  Google Scholar 

  37. Francis JC, Hui SK, Mahoney Jr D, et al. Diagnostic challenges in patients with bleeding phenotype and von Willebrand exon 28 polymorphism D1472H. Haemophilia. 2014;20(3):e211–4.

    Article  CAS  PubMed  Google Scholar 

  38. Larsen JB, Bor MV, Hvas AM. Combined oral contraceptives do not influence von Willebrand factor related biomarkers despite an induced acute phase response. Thromb Res. 2015;135(1):208–11.

    Article  CAS  PubMed  Google Scholar 

  39. Mills HL, Abdel-Baki MS, Teruya J, et al. Platelet function defects in adolescents with heavy menstrual bleeding. Haemophilia. 2014;20(2):249–54.

    Article  CAS  PubMed  Google Scholar 

  40. Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol. 2010;134(6):955–63.

    Article  PubMed  Google Scholar 

  41. Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, et al. Bleeding in carriers of hemophilia. Blood. 2006;108(1):52–6.

    Article  CAS  PubMed  Google Scholar 

  42. Winikoff R, Lee C. Hemophilia carrier status and counseling the symptomatic and asymptomatic adolescent. J Pediatr Adolesc Gynecol. 2010;23 Suppl 6:S43–7.

    Article  PubMed  Google Scholar 

  43. Edlund M. Nonhormonal treatments for heavy menstrual bleeding. J Womens Health (Larchmt). 2011;20(11):1645–53.

    Article  Google Scholar 

  44. Lukes AS, Kouides PA, Moore KA. Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding. Womens Health (Lond Engl). 2011;7(2):151–8.

    Article  CAS  Google Scholar 

  45. James AH, Kouides PA, Abdul-Kadir R, et al. Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol Reprod Biol. 2011;158:124–34.

    Article  PubMed  Google Scholar 

  46. DeVore GR, Owens O, Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding—a double-blind randomized control study. Obstet Gynecol. 1982;59(3):285–91.

    CAS  PubMed  Google Scholar 

  47. Robins JC. Therapies for the treatment of abnormal uterine bleeding. Curr Womens Health Rep. 2001;1(3):196–201.

    CAS  PubMed  Google Scholar 

  48. Grover S. Bleeding disorders and heavy menses in adolescents. Curr Opin Obstet Gynecol. 2007;19(5):415–9.

    Article  PubMed  Google Scholar 

  49. Kantartzis KL, Sucato GS. Menstrual suppression in the adolescent. J Pediatr Adolesc Gynecol. 2013;26(3):132–7.

    Article  PubMed  Google Scholar 

  50. Matteson KA, Rahn DD, Wheeler 2nd TL, et al. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol. 2013;121(3):632–43.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Hashim A. Medical treatment of idiopathic heavy menstrual bleeding. What is new? Arch Gynecol Obstet. 2013;287(2):251–60.

    Article  PubMed  Google Scholar 

  52. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol. 2007;110(6):1493–5.

    Article  Google Scholar 

  53. Paterson H, Ashton J, Harrison-Woolrych M. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception. 2009;79:433–8.

    Article  CAS  PubMed  Google Scholar 

  54. Xu L, Lee BS, Asif S, et al. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. Int J Womens Health. 2014;6:547–54.

    PubMed  PubMed Central  Google Scholar 

  55. Wilkinson JP, Kadir RA. Management of abnormal uterine bleeding in adolescents. J Pediatr Adolesc Gynecol. 2010;23 Suppl 6:S22–30.

    Article  PubMed  Google Scholar 

  56. Sokkary N, Dietrich JE. Management of heavy menstrual bleeding in adolescents. Curr Opin Obstet Gynecol. 2012;24(5):275–80.

    Article  PubMed  Google Scholar 

  57. Wang W, Bourgeois T, Klima J, et al. Iron deficiency and fatigue in adolescent females with heavy menstrual bleeding. Haemophilia. 2013;19:225–30.

    Article  PubMed  Google Scholar 

  58. Revel-Vilk S, Paltiel O, Lipschuetz M, et al. Underdiagnosed menorrhagia in adolescents is associated with underdiagnosed anemia. J Pediatr. 2012;160:468–72.

    Article  PubMed  Google Scholar 

  59. Chigbu CO, Iloabachie GC. Intrauterine Foley urethral catheter for postmyomectomy uterine bleeding. Int J Gynaecol Obstet. 2006;95:175–6.

    Article  CAS  PubMed  Google Scholar 

  60. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG. 2009;116:748–57.

    Article  CAS  PubMed  Google Scholar 

  61. Hurley VA, Beischer NA. Cervical pregnancy: hysterectomy avoided with the use of a large Foley catheter balloon. Aust N Z J Obstet Gynaecol. 1988;28:230–2.

    Article  CAS  PubMed  Google Scholar 

  62. Hamani Y, Ben-Shachar I, Kalish Y, et al. Intrauterine balloon tamponade as a treatment for immune thrombocytopenic purpura-induced severe uterine bleeding. Fertil Steril. 2010;94(7):2769.e13–2769.e5.

    Article  Google Scholar 

  63. Bowkley CW, Dubel GJ, Haas RA, et al. Uterine artery embolization for control of life-threatening hemorrhage at menarche: brief report. J Vasc Interv Radiol. 2007;18:127–31.

    Article  PubMed  Google Scholar 

  64. Vedantham S, Goodwin SC, McLucas B, et al. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol. 1997;176:938–48.

    Article  CAS  PubMed  Google Scholar 

  65. Firouznia K, Ghanaati H, Sanaati M, et al. Pregnancy after uterine artery embolization for symptomatic fibroids: a series of 15 pregnancies. AJR Am J Roentgenol. 2009;192:1588–92.

    Article  PubMed  Google Scholar 

  66. Yeasmin S, Nakayama K, Ishibashi M, et al. Microwave endometrial ablation as an alternative to hysterectomy for the emergent control of uterine bleeding in patients who are poor surgical candidates. Arch Gynecol Obstet. 2009;280:279–82.

    Article  PubMed  Google Scholar 

  67. American College of Obstetricians and Gynecologists. Endometrial ablation. ACOG Practice Bulletin No. 81. Obstet Gynecol. 2007;109:1233–48.

    Article  Google Scholar 

  68. Nichols C, Gill E. Thermal balloon endometrial ablation for management of acute uterine hemorrhage. Obstet Gynecol. 2002;100(5 Pt 2):1092–4.

    PubMed  Google Scholar 

  69. Sheehy S, Cohen G, Owen KR. Self-management of diabetes in children and young adults using technology and smartphone applications. Curr Diabetes Rev. 2014;10(5):298–301.

    Article  PubMed  Google Scholar 

  70. van Vliet D, van Horck M, van de Kant K, et al. Electronic monitoring of symptoms and lung function to assess asthma control in children. Ann Allergy Asthma Immunol. 2014;113(3):257.e1–62.e1.

    Google Scholar 

  71. Joshi S, Dimov V. Use of new technology to improve utilization and adherence to immunotherapy. World Allergy Organ J. 2014;7(1):29.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Trent M, Thompson C, Tomaszewski K. Text messaging support for Urban adolescents and young adults using injectable contraception: outcomes of the DepoText pilot trial. J Adolesc Health. 2015;57(1):100–6.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Dietrich JE, Santos XM, Bercaw JL, et al. Improving education and advocacy for young women with menorrhagia with use of innovative technology. Abstract, ISTH Congress, 2015.

    Google Scholar 

  74. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia. 2005;11(4):295–307.

    Article  CAS  PubMed  Google Scholar 

  75. Von Mackensen S. Quality of life in women with bleeding disorders. Haemophilia. 2011;17 Suppl 1:33–7.

    Article  Google Scholar 

  76. Khair K, Holland M, Pollard D. The experience of girls and young women with inherited bleeding disorders. Haemophilia. 2013;19(5):e276–81.

    Article  CAS  PubMed  Google Scholar 

  77. Rae C, Furlong W, Horsman J, et al. Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life. Haemophilia. 2013;19:385–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatrics, Section of Hematology/Oncology, Young Women’s Bleeding Disorder Clinic, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX, USA

    Lakshmi V. Srivaths MD

  2. Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA

    Jennifer L. Bercaw MD

  3. Departments of OB/GYN and Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, 6651 Main Street, Ste 1050, Houston, 77030, TX, USA

    Jennifer E. Dietrich M.D., M.Sc.

Authors
  1. Lakshmi V. Srivaths MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer L. Bercaw MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer E. Dietrich M.D., M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer E. Dietrich M.D., M.Sc. .

Editor information

Editors and Affiliations

  1. Departments of Pathology & Immunology, Pediatrics, and Medicine, Baylor College of Medicine Division of Transfusion Medicine & Coagulation Texas Children’s Hospital, Houston, Texas, USA

    Jun Teruya

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Srivaths, L.V., Bercaw, J.L., Dietrich, J.E. (2016). Heavy Menstrual Bleeding. In: Teruya, J. (eds) Management of Bleeding Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-30726-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30726-8_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30724-4

  • Online ISBN: 978-3-319-30726-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation